{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:13:57Z","timestamp":1792113237901,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejca.2024.115064","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T13:08:02Z","timestamp":1728392882000},"page":"115064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group"],"prefix":"10.1016","volume":"212","author":[{"given":"Khaled","family":"Elsayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella","family":"Guenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalid","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Trautinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Waldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Boterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Meijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Dobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Duque-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Riggenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Elsheshtawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Niezink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Scarisbrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Neelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Maklad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Kouloulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simontacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2022.104108","article-title":"Recent advances on cutaneous lymphoma epidemiology","volume":"51","author":"Dobos","year":"2022","journal-title":"Presse Med"},{"key":"10.1016\/j.ejca.2024.115064_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"31","key":"10.1016\/j.ejca.2024.115064_bib3","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/bjd.18089","article-title":"Characteristics associated with significantly worse quality of life in mycosis fungoides\/S\u00e9zary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study","volume":"182","author":"Molloy","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2024.115064_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113073","article-title":"Quality of life in cutaneous lymphoma varies by lymphoma type","volume":"190","author":"Lawrance","year":"2023","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2008.08992.x","article-title":"Quality of life and psychological distress in patients with cutaneous lymphoma","volume":"160","author":"Sampogna","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.141.3.325","article-title":"Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma","volume":"141","author":"Demierre","year":"2005","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib9","first-page":"537","article-title":"S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): update 2021","volume":"20","author":"Dippel","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2024.115064_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 update 2023","author":"Latzka","year":"2023","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjd.17240","article-title":"British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018","volume":"180","author":"Gilson","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.19252","article-title":"Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study","volume":"184","author":"Quaglino","year":"2021","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000475634","article-title":"Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T-cell lymphoma","volume":"40","author":"Elsayad","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2024.115064_bib15","article-title":"Quality of life in mycosis fungoides and S\u00e9zary-syndrome patients undergoing low-dose total skin electron beam therapy with or without maintenance therapy","author":"Nawar","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2020.01.046","article-title":"A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: reduction of disease burden and improvement in quality of life","volume":"83","author":"Song","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2015.08.041","article-title":"Total skin electron beam for primary cutaneous T-cell lymphoma","volume":"93","author":"Elsayad","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijrobp.2014.11.033","article-title":"Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique","volume":"92","author":"Heumann","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2024.115064_bib19","first-page":"77","article-title":"Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: a retrospective analysis of treatment outcomes and selection for high or low dose schedule","volume":"33","author":"Smits","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib20","first-page":"205","article-title":"What is new about primary cutaneous B cell lymphomas","volume":"158","author":"Blanchard","year":"2023","journal-title":"Ital J Dermatol Venerol"},{"key":"10.1016\/j.ejca.2024.115064_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19799","article-title":"Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: a multicentric study in 100 patients. J Eur","author":"Schirren","year":"2024","journal-title":"Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib22","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ijrobp.2016.03.023","article-title":"Radiation therapy for primary cutaneous anaplastic large cell lymphoma: an international lymphoma radiation oncology group multi-institutional experience","volume":"95","author":"Million","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00066-018-1277-3","article-title":"Ansprechraten und Rezidivmuster nach Niedrigdosis-Bestrahlung mit 4 Gy bei Patienten mit indolenten Lymphomen","volume":"194","author":"K\u00f6nig","year":"2018","journal-title":"Strahl Onkol"},{"key":"10.1016\/j.ejca.2024.115064_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdin.2024.07.002","article-title":"Health-related quality of life in primary cutaneous B-cell lymphoma following local radiotherapy","author":"Heger","year":"2024","journal-title":"JAAD Int"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hon.2919","article-title":"Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"39","author":"Kraft","year":"2021","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010221","article-title":"High plus low dose radiation strategy in combination with TIGIT and PD1 blockade to promote systemic antitumor responses","volume":"14","author":"Barsoumian","year":"2022","journal-title":"Cancers"},{"issue":"7668","key":"10.1016\/j.ejca.2024.115064_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2024.115064_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ejca.2024.115064_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1339857","article-title":"TREX1 dictates the immune fate of irradiated cancer cells","volume":"6","author":"Vanpouille-Box","year":"2017","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrclinonc.2016.183","article-title":"Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy","volume":"14","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2024.115064_bib32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.ejca.2024.115064_bib33","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2024.115064_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fonc.2012.00191","article-title":"Radiation-induced effects and the immune system in cancer","volume":"2","author":"Kaur","year":"2012","journal-title":"Front Oncol"},{"issue":"7637","key":"10.1016\/j.ejca.2024.115064_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1078-0432.CCR-07-4485","article-title":"Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha","volume":"14","author":"Shiraishi","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/cco.2018.10.01","article-title":"Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment","volume":"8","author":"Jennings","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"25","key":"10.1016\/j.ejca.2024.115064_bib40","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2015-12-611830","article-title":"How I treat mycosis fungoides and Sezary syndrome","volume":"127","author":"Whittaker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2024.115064_bib41","article-title":"Optimizing palliative focal radiation therapy dose in cutaneous T-cell lymphoma: how low can you go?","author":"Patel","year":"2022","journal-title":"Pr Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","article-title":"Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis","volume":"92","author":"Kamstrup","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2024.115064_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2017.05.052","article-title":"The results of Low dose Total Skin Electron Beam Radiotherapy (TSEB), in patients with mycosis fungoides from the UK cutaneous lymphoma group","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"12","key":"10.1016\/j.ejca.2024.115064_bib46","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/annonc\/mdv473","article-title":"Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution","volume":"26","author":"Hosing","year":"2015","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib47","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.clml.2014.09.013","article-title":"Long-term complete responses to combination therapies and allogeneic stem cell transplants in patients with sezary syndrome","volume":"15","author":"Polansky","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaad.2012.12.975","article-title":"Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma","volume":"69","author":"DeSimone","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2012.05.034","article-title":"Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma","volume":"85","author":"Thomas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.prro.2023.03.015","article-title":"Single-fraction radiation therapy for localized cutaneous T-cell lymphoma","volume":"13","author":"Wang","year":"2023","journal-title":"Pr Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib53","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2007.11.039","article-title":"A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides","volume":"71","author":"Kamstrup","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ijrobp.2017.05.052","article-title":"The results of low-dose total skin electron beam radiation therapy (TSEB) in patients with mycosis fungoides from the UK cutaneous lymphoma group","volume":"99","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2024.115064_bib55","article-title":"Low-dose total skin electron beam therapy as part of a multimodality regimen for treatment of s\u00e9zary syndrome: clinical, immunologic, and molecular analysis","author":"Durgin","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2024.115064_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.02.052","article-title":"Ultra-hypofractionated low-dose total skin electron beam in advanced stage mycosis fungoides and S\u00e9zary syndrome","author":"Elsayad","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ejca.2024.115064_bib57","article-title":"Fine-tuning low-dose total skin electron therapy for optimal management of cutaneous T-cell lymphoma: a comparative analysis of regimens","volume":"9","author":"Laughlin","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib58","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijrobp.2017.08.010","article-title":"Recommendations for the optimal radiation dose in patients with primary cutaneous anaplastic large cell lymphoma: a report of the dutch cutaneous lymphoma group","volume":"99","author":"Melchers","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2024.115064_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.11.019","article-title":"Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small\/medium T-Cell lymphoproliferative disorder","volume":"178","author":"Ward","year":"2023","journal-title":"Radio Oncol"},{"key":"10.1016\/j.ejca.2024.115064_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.17352","article-title":"Radiotherapy in the treatment of primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder","author":"Wu","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2024.115064_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15355","article-title":"Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group","author":"van Santen","year":"2017","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.ejca.2024.115064_bib62","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2024.115064_bib63","doi-asserted-by":"crossref","first-page":"S1131","DOI":"10.1016\/S0167-8140(24)00959-9","article-title":"Mycosis Fungoides with Large Cell Transformation: Radiotherapy Dose Response and Patient Outcomes","volume":"194","author":"Johnstone","year":"2024","journal-title":"Radiother Oncol"},{"issue":"1 Pt 1","key":"10.1016\/j.ejca.2024.115064_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1067\/mjd.2000.105510","article-title":"Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides","volume":"43","author":"Wilson","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ejca.2024.115064_bib65","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaad.2012.09.056","article-title":"Improvement in peripheral blood disease burden in patients with Sezary syndrome and leukemic mycosis fungoides after total skin electron beam therapy","volume":"68","author":"Klein","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ejca.2024.115064_bib66","first-page":"279","article-title":"Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma","volume":"20","author":"Elsayad","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib67","doi-asserted-by":"crossref","first-page":"S114477","DOI":"10.1016\/j.ejca.2024.114477","article-title":"A-167 Durable disease control with low-dose total skin electron beam therapy combined with maintenance treatment for patients with erythrodermic mycosis fungoides and S\u00e9zary syndrome","volume":"211","author":"Elsayad","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.115064_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2020.10.007","article-title":"Maintenance therapy in patients with mycosis fungoides or S\u00e9zary syndrome: a neglected topic","volume":"142","author":"Stadler","year":"2020","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020313","article-title":"Novel theranostic approaches targeting CCR4-Receptor, current status and translational prospectives: a systematic review","volume":"16","author":"Gorica","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.ejca.2024.115064_bib70","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10094","key":"10.1016\/j.ejca.2024.115064_bib71","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.19.01056","article-title":"Pembrolizumab in relapsed and refractory mycosis fungoides and s\u00e9zary syndrome: a multicenter phase II study","volume":"38","author":"Khodadoust","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.115064_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.adro.2017.06.004","article-title":"Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma","author":"Smith","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib74","doi-asserted-by":"crossref","DOI":"10.1159\/000470845","article-title":"Renaissance of low-dose radiotherapy concepts for cutaneous lymphomas","volume":"40","author":"Dabaja","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00066-019-01541-7","article-title":"Deeskalierte Strahlentherapie beim indolenten prim\u00e4r kutanen B-Zell-Lymphom","volume":"196","author":"Oertel","year":"2020","journal-title":"Strahl Onkol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/10428194.2015.1040012","article-title":"Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy","volume":"57","author":"Akhtari","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2024.115064_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/jvc2.403","article-title":"Ultra\u2010low dose radiation therapy for primary cutaneous indolent B\u2010cell lymphomas","author":"Kasera","year":"2024","journal-title":"JEADV Clin Pract"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib78","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ijrobp.2024.07.110","article-title":"Defining the Role of Radiotherapy for Indolent, Primary Cutaneous B-Cell Lymphoma \u2013 First Results from a Multicenter Registry by the International Lymphoma Radiation Oncology Group (ILROG)","volume":"120","author":"Oertel","year":"2024","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"7","key":"10.1016\/j.ejca.2024.115064_bib79","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(24)00133-9","article-title":"Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial","volume":"11","author":"Gunther","year":"2024","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib80","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2024.115064_bib81","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2024.115064_bib82","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaad.2017.07.053","article-title":"Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: a retrospective study","volume":"78","author":"Goyal","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib83","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","author":"Hamilton","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejca.2024.115064_bib84","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"5","key":"10.1016\/j.ejca.2024.115064_bib85","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1159\/000522053","article-title":"Radiotherapy as a treatment option for local disease control in primary cutaneous diffuse large b-cell lymphoma, leg type","volume":"238","author":"Zehnder","year":"2022","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib86","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radio Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.115064_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2019.02.055","article-title":"Phase 2 study of dose-reduced consolidation radiation therapy in diffuse large B-cell lymphoma","volume":"105","author":"Kelsey","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2024.115064_bib88","article-title":"Defining patient empowerment from a radiation oncology perspective: an expert and patient consensus. Vienna","author":"Shouman","year":"2023","journal-title":"Austria"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492401030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492401030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:31:22Z","timestamp":1737649882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492401030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":88,"alternative-id":["S095980492401030X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.115064","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.115064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115064"}}